Chicago-based physician to contribute through Anosh Inc Foundation and host local fundraiser in support of federal agents ...

The Anosh Foundation is a nonprofit organization dedicated to advancing ethical and accessible healthcare worldwide. Founded ...

SugarTop Buddery is known for its music and artist collaborations, stylish pre-rolls, and emphasis on social equity and women ...

(“LIXTE” or the “Company”) ( Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced that the medical journal Nature has published findings by a team of physician-scientists ...

Candel was added to the Russell 2500 Value ® Index, Russell Small Cap Value ® Index, Russell 2000 Value ® Index, Russell Microcap Value ® Index, and Russell 3000E ® Value Index. Additionally, the ...

NORCROSS, Ga., July 09, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with metabolic dysfunction-associated ...

About IPC Digital Health™ IPC Digital Health™ is the innovation arm of the Independent Pharmacy Cooperative, the country’s largest GPO owned by independent pharmacies. Through its iCare+™ platform, ...

Dr. Edwin Tucker is departing his role as Chief Medical Officer effective August 1, 2025. Dr. Daniel Adelman, an experienced clinical development executive and member of Jasper’s scientific advisory ...

Iambic to receive up to $25 million through a combination of upfront and expected near-term performance-based milestone payments for services related to Revolution Medicines’ access to Iambic’s ...

About Evoke Pharma, Inc. Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat GI disorders and diseases. The company developed, commercialized and markets ...

Salarius also announces continued progress in its planned merger with Decoy Therapeutics Inc. (Decoy). Under the definitive agreement announced on January 13, 2025, Decoy will merge with a wholly ...

-Following the Positive Data Safety Monitoring Board Recommendation, Enrollment of Cohort 2 is Expected to Begin in Q4 2025- ...